• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

(+)-、(-)-和(±)-茚雌酚A和B对微管聚合的影响。

Effects of (+)-, (-)- and (+/-)-indenestrols A and B on microtubule polymerization.

作者信息

Oda T, Sakakibara Y, Sato Y, Hanzawa H, Hata T

机构信息

Kyoritsu College of Pharmacy, Shibakoen 1-chome, Minato-ku, Tokyo, Japan.

出版信息

Chem Pharm Bull (Tokyo). 1992 Mar;40(3):588-92. doi: 10.1248/cpb.40.588.

DOI:10.1248/cpb.40.588
PMID:1611675
Abstract

Indenestrol A (IA) is a metabolite of diethylstilbestrol (DES), and indenestrol B (IB) is an analog of IA. IA was simply obtained from E,E-dienestrol in the presence of dilute sulfuric acid, and a mixture of IA and IB was formed by thermal cyclization of E,E-dienestrol. In order to elucidate the effects of optically active IA and IB on microtubule assembly, the IA and IB enantiomers were separated to greater than 99% purity by high-pressure liquid chromatography using a chiral column. The di(4-bromobenzoate) of (-)-IB was analyzed by X-ray crystallography and its absolute structure was determined as C(3)-S. The (+)-, (-)-, and (+/-)-indenestrols A and B were shown to be inhibitors of microtubule assembly in vitro using microtubule proteins from porcine brain. (+/-)-IB is more active than (+/-)-IA, and the order of inhibitory activity of the enantiomers on microtubule assembly was (+)-IB greater than (+)-IA greater than (-)-IA greater than (-)-IB.

摘要

茚雌酚A(IA)是己烯雌酚(DES)的一种代谢产物,茚雌酚B(IB)是IA的类似物。IA可在稀硫酸存在的情况下简单地由E,E-二烯雌酚制得,并且IA和IB的混合物通过E,E-二烯雌酚的热环化反应形成。为了阐明旋光性IA和IB对微管组装的影响,使用手性柱通过高压液相色谱法将IA和IB对映体分离至纯度大于99%。通过X射线晶体学分析了(-)-IB的二(4-溴苯甲酸酯),并确定其绝对结构为C(3)-S。使用来自猪脑的微管蛋白,(+)-、(-)-和(+/-)-茚雌酚A和B在体外被证明是微管组装的抑制剂。(+/-)-IB比(+/-)-IA更具活性,并且对映体对微管组装的抑制活性顺序为(+)-IB大于(+)-IA大于(-)-IA大于(-)-IB。

相似文献

1
Effects of (+)-, (-)- and (+/-)-indenestrols A and B on microtubule polymerization.(+)-、(-)-和(±)-茚雌酚A和B对微管聚合的影响。
Chem Pharm Bull (Tokyo). 1992 Mar;40(3):588-92. doi: 10.1248/cpb.40.588.
2
Effects of (+)-, (-)- and (+/-)-indenestrols A and B on microtubule distribution and cytotoxicity in Chinese hamster V79 cells.(+)-、(-)-和(±)-茚雌酚A及B对中国仓鼠V79细胞微管分布和细胞毒性的影响
Mutat Res. 1993 Oct;289(2):223-30. doi: 10.1016/0027-5107(93)90073-o.
3
Effects of the ethyl and benzyl ethers of indenestrols A and B on cytotoxicity in Chinese hamster V79 cells.茚雌酚A和B的乙酯和苄酯对中国仓鼠V79细胞细胞毒性的影响。
Biol Pharm Bull. 2000 Jan;23(1):119-21. doi: 10.1248/bpb.23.119.
4
Diethylstilbestrol metabolites and analogs. Stereochemical probes for the estrogen receptor binding site.
J Biol Chem. 1989 Apr 5;264(10):5642-7.
5
Indanyl analogs of diethylstilbestrol: differential interaction with prostaglandin H synthase.
Carcinogenesis. 1989 May;10(5):839-45. doi: 10.1093/carcin/10.5.839.
6
Lack of mutagenicity of diethylstilbestrol metabolite and analog, (+/-)-indenestrols A and B, in bacterial assays.己烯雌酚代谢物及类似物(±)-茚雌酚A和B在细菌试验中无致突变性。
Mutat Res. 1996 Jul 5;368(3-4):261-5. doi: 10.1016/s0165-1218(96)90067-1.
7
Inhibition of microtubule polymerization by synthetic estrogens: formation of a ribbon structure.合成雌激素对微管聚合的抑制作用:带状结构的形成。
J Biochem. 1987 May;101(5):1247-52. doi: 10.1093/oxfordjournals.jbchem.a121988.
8
Inhibition of DNA topoisomerase I activity by diethylstilbestrol and its analogues.己烯雌酚及其类似物对DNA拓扑异构酶I活性的抑制作用。
Biol Pharm Bull. 1993 Jul;16(7):708-10. doi: 10.1248/bpb.16.708.
9
Estrogen receptor stereochemistry: receptor binding and hormonal responses.
J Steroid Biochem. 1987;27(1-3):281-90. doi: 10.1016/0022-4731(87)90319-0.
10
Inhibition by (+/-)-indenestrol A of interferon gamma-stimulated nitric oxide formation in murine macrophage RAW 264.7 cells.(±)-茚雌酚A对小鼠巨噬细胞RAW 264.7细胞中γ-干扰素刺激的一氧化氮生成的抑制作用。
Mutat Res. 2003 Jan 10;534(1-2):187-95. doi: 10.1016/s1383-5718(02)00275-9.